What are the recommended oral tinidazole tablet doses for adults and children for trichomoniasis, bacterial vaginosis, amoebic dysentery, and giardiasis, and how should dosing be adjusted in hepatic impairment or renal failure?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Tinidazole Dosing Recommendations

Trichomoniasis

For trichomoniasis, administer tinidazole 2 g orally as a single dose, which achieves cure rates of 95% or higher. 1, 2

  • This single-dose regimen offers superior convenience and compliance compared to multi-day regimens, particularly important for ensuring simultaneous partner treatment 1
  • All sexual partners must be treated simultaneously with the same 2 g single dose, regardless of symptoms 3, 4
  • Patients must abstain from sexual activity until both partners complete treatment and are asymptomatic 3, 4

Critical Alcohol Avoidance

  • Patients must completely avoid all alcoholic beverages during treatment and for at least 24 hours after the last dose to prevent severe disulfiram-like reactions 3, 4

Giardiasis

For giardiasis, administer tinidazole 2 g orally as a single dose in adults, or approximately 50 mg/kg (up to 2 g maximum) as a single dose in children. 5, 2

  • Single-dose therapy achieves parasitological cure rates of 88-100% 2
  • Tinidazole has demonstrated significantly superior efficacy compared to metronidazole for giardiasis (P < 0.05) 5
  • Tinidazole has proven effective even in metronidazole-resistant giardiasis cases 1

Intestinal Amoebiasis

For intestinal amoebiasis, administer tinidazole 2 g orally once daily for 3 consecutive days in adults, or approximately 50 mg/kg once daily for 3 days in children. 5, 2

  • This regimen achieves parasitological cure rates of approximately 95% with complete or marked symptom improvement 2
  • Once-daily dosing yields slightly better results than multiple daily dose regimens 1
  • Tinidazole demonstrated significantly superior efficacy compared to metronidazole for amebiasis (P < 0.05) 5

Amoebic Liver Abscess

For amoebic liver abscess, administer tinidazole 2 g orally once daily for 3 consecutive days. 5, 2

  • This regimen achieves cure rates of approximately 94% 2
  • Some cases may require extended therapy for 5-7 days, though this requires further evaluation 6

Bacterial Vaginosis

For bacterial vaginosis, administer tinidazole 2 g orally as a single dose or 1 g once daily for 5 days. 6

  • Single-dose therapy achieves clinical improvement and/or microbiological cure in 59-96% of patients 6
  • Sexual partners do not require treatment, as multiple trials demonstrate this does not improve cure rates or prevent recurrence 7

Special Population Adjustments

Hepatic Impairment

  • Use of tinidazole in patients with severe hepatic impairment (Child-Pugh class C) is not recommended, as no pharmacokinetic data exist for this population. 5
  • Tinidazole is eliminated primarily by hepatic metabolism (approximately 63%) 5

Renal Failure

  • Dose adjustment does not appear necessary based on renal function, as tinidazole has minimal renal elimination. 5

Pregnancy

  • No specific tinidazole data available in the provided evidence; metronidazole remains the preferred agent with established safety data 8, 7

Pharmacokinetic Advantages

  • Tinidazole has 100% bioavailability after oral administration 5
  • Plasma elimination half-life of 12.3-12.5 hours (compared to metronidazole's 7.3 hours) allows for less frequent dosing 1, 5
  • Minimal plasma protein binding (12%) 5
  • Peak serum levels occur approximately 2 hours after administration but persist longer than metronidazole 1

Tolerability Profile

  • Most commonly reported adverse effects (>1%) include bitter taste, nausea, abdominal discomfort, anorexia, vomiting, and fatigue 5
  • Side-effects occur in approximately 9.5-10.9% of patients, with severe reactions in only 1.4-2.4% 2
  • Rarely, vomiting may occur with large single doses, requiring re-treatment with a multiple-dose regimen 1

References

Guideline

Treatment of Trichomonas Urethritis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Trichomonas Vaginalis Detected in Urine

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Tinidazole: a nitroimidazole antiprotozoal agent.

Clinical therapeutics, 2005

Guideline

Bacterial Vaginosis Treatment with Metronidazole

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.